M&A / Deals AI giant Anthropic buys Coefficient Bio for $400m PharmaphorumAnthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.M&A / DealsRead full story pharminent April 7, 2026 (Last updated: April 7, 2026) Pharmaphorum Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio. M&A / DealsRead full story Post navigation Previous: Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3Next: Sanofi immune drug hopeful posts mixed results in mid-stage tests Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026